{
  "data": {
    "id": "org_centre-for-innovation-in-regulatory-science",
    "slug": "centre-for-innovation-in-regulatory-science",
    "name": "Centre for Innovation in Regulatory Science",
    "short_name": "CIRS",
    "type": "research",
    "tier": 3,
    "homepage": "https://cirsci.org",
    "country_code": "GB",
    "reliability_note": null,
    "url": "https://statorigin.org/sources/centre-for-innovation-in-regulatory-science",
    "documents": [
      {
        "title": "New Drug Approvals by Six Major Authorities 2016-2025",
        "url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 14
      }
    ],
    "statistics": [
      {
        "id": "stat_95521VRV5DKE5XRF9QPEAQ2YQ2",
        "url": "https://statorigin.org/stat/stat_95521VRV5DKE5XRF9QPEAQ2YQ2",
        "indicator": {
          "slug": "common-new-active-substance-approvals-across-major-regulatory-authorities-multi-",
          "name": "Common new active substance approvals across major regulatory authorities (multi-year total)",
          "definition": "Total count of new active substances approved across all designated major regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GLOBAL",
          "name": "Global",
          "type": "world"
        },
        "period": {
          "start": "2016-01-01",
          "end": "2020-12-31",
          "type": "year"
        },
        "value": 37,
        "value_text": "37",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "The number of new active substances approved by all six authorities increased from 37 in 2016–2020 to 52 in 2021–2025, reflecting continued growth in global approvals.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2020). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_95521VRV5DKE5XRF9QPEAQ2YQ2",
          "bibtex": "@misc{cirs2020commonaq2yq2,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2020},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_95521VRV5DKE5XRF9QPEAQ2YQ2},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_JEA7Z82C61VQJ5X81GNSQRK3HC",
        "url": "https://statorigin.org/stat/stat_JEA7Z82C61VQJ5X81GNSQRK3HC",
        "indicator": {
          "slug": "common-new-active-substance-approvals-across-major-regulatory-authorities-multi-",
          "name": "Common new active substance approvals across major regulatory authorities (multi-year total)",
          "definition": "Total count of new active substances approved across all designated major regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GLOBAL",
          "name": "Global",
          "type": "world"
        },
        "period": {
          "start": "2021-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 52,
        "value_text": "52",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "The number of new active substances approved by all six authorities increased from 37 in 2016–2020 to 52 in 2021–2025, reflecting continued growth in global approvals.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_JEA7Z82C61VQJ5X81GNSQRK3HC",
          "bibtex": "@misc{cirs2025commonqrk3hc,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_JEA7Z82C61VQJ5X81GNSQRK3HC},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_BMDC33RH0WZRBZQQAKRN7VZZF1",
        "url": "https://statorigin.org/stat/stat_BMDC33RH0WZRBZQQAKRN7VZZF1",
        "indicator": {
          "slug": "median-drug-approval-time",
          "name": "Median drug approval time",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CA",
          "name": "Canada",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 369,
        "value_text": "369 days",
        "unit": "days",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "PMDA recorded the shortest median approval time in 2025 (292 days), followed by FDA (322 days), TGA (350 days), Health Canada (369 days), Swissmedic (413 days) and EMA (448 days).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_BMDC33RH0WZRBZQQAKRN7VZZF1",
          "bibtex": "@misc{cirs2025median7vzzf1,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_BMDC33RH0WZRBZQQAKRN7VZZF1},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_EF3VJQ4JDCGSTRMV71FMV5MD25",
        "url": "https://statorigin.org/stat/stat_EF3VJQ4JDCGSTRMV71FMV5MD25",
        "indicator": {
          "slug": "median-drug-approval-time",
          "name": "Median drug approval time",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CH",
          "name": "Switzerland",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 413,
        "value_text": "413 days",
        "unit": "days",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "PMDA recorded the shortest median approval time in 2025 (292 days), followed by FDA (322 days), TGA (350 days), Health Canada (369 days), Swissmedic (413 days) and EMA (448 days).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_EF3VJQ4JDCGSTRMV71FMV5MD25",
          "bibtex": "@misc{cirs2025medianv5md25,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_EF3VJQ4JDCGSTRMV71FMV5MD25},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_B1EWGR1ZAMXV2PVS7F6YTM8M93",
        "url": "https://statorigin.org/stat/stat_B1EWGR1ZAMXV2PVS7F6YTM8M93",
        "indicator": {
          "slug": "median-drug-approval-time",
          "name": "Median drug approval time",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "JP",
          "name": "Japan",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 292,
        "value_text": "292 days",
        "unit": "days",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "PMDA recorded the shortest median approval time in 2025 (292 days), followed by FDA (322 days), TGA (350 days), Health Canada (369 days), Swissmedic (413 days) and EMA (448 days).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_B1EWGR1ZAMXV2PVS7F6YTM8M93",
          "bibtex": "@misc{cirs2025mediantm8m93,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_B1EWGR1ZAMXV2PVS7F6YTM8M93},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      },
      {
        "id": "stat_1VFYZ9T38HBSHXMECZ1SEKZY6R",
        "url": "https://statorigin.org/stat/stat_1VFYZ9T38HBSHXMECZ1SEKZY6R",
        "indicator": {
          "slug": "median-drug-approval-time",
          "name": "Median drug approval time",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 322,
        "value_text": "322 days",
        "unit": "days",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "PMDA recorded the shortest median approval time in 2025 (292 days), followed by FDA (322 days), TGA (350 days), Health Canada (369 days), Swissmedic (413 days) and EMA (448 days).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_1VFYZ9T38HBSHXMECZ1SEKZY6R",
          "bibtex": "@misc{cirs2025medianekzy6r,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_1VFYZ9T38HBSHXMECZ1SEKZY6R},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      },
      {
        "id": "stat_ZZXHP38XZ0R6FT1819M364QJ8E",
        "url": "https://statorigin.org/stat/stat_ZZXHP38XZ0R6FT1819M364QJ8E",
        "indicator": {
          "slug": "median-drug-approval-time",
          "name": "Median drug approval time",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "AU",
          "name": "Australia",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 350,
        "value_text": "350 days",
        "unit": "days",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "PMDA recorded the shortest median approval time in 2025 (292 days), followed by FDA (322 days), TGA (350 days), Health Canada (369 days), Swissmedic (413 days) and EMA (448 days).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_ZZXHP38XZ0R6FT1819M364QJ8E",
          "bibtex": "@misc{cirs2025median64qj8e,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_ZZXHP38XZ0R6FT1819M364QJ8E},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      },
      {
        "id": "stat_0K03PFQGYKXM0AKXNAG418YP3K",
        "url": "https://statorigin.org/stat/stat_0K03PFQGYKXM0AKXNAG418YP3K",
        "indicator": {
          "slug": "median-drug-approval-time",
          "name": "Median drug approval time",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 448,
        "value_text": "448 days",
        "unit": "days",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "PMDA recorded the shortest median approval time in 2025 (292 days), followed by FDA (322 days), TGA (350 days), Health Canada (369 days), Swissmedic (413 days) and EMA (448 days).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_0K03PFQGYKXM0AKXNAG418YP3K",
          "bibtex": "@misc{cirs2025median18yp3k,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_0K03PFQGYKXM0AKXNAG418YP3K},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      },
      {
        "id": "stat_YMXBXJ0P43KQAEPECM9ZVVQ029",
        "url": "https://statorigin.org/stat/stat_YMXBXJ0P43KQAEPECM9ZVVQ029",
        "indicator": {
          "slug": "new-active-substance-approvals",
          "name": "New active substance approvals",
          "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CA",
          "name": "Canada",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 44,
        "value_text": "44",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_YMXBXJ0P43KQAEPECM9ZVVQ029",
          "bibtex": "@misc{cirs2025activevvq029,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_YMXBXJ0P43KQAEPECM9ZVVQ029},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_N08APVFSYJH011YV93A6FEWNP8",
        "url": "https://statorigin.org/stat/stat_N08APVFSYJH011YV93A6FEWNP8",
        "indicator": {
          "slug": "new-active-substance-approvals",
          "name": "New active substance approvals",
          "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "CH",
          "name": "Switzerland",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 34,
        "value_text": "34",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_N08APVFSYJH011YV93A6FEWNP8",
          "bibtex": "@misc{cirs2025activefewnp8,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_N08APVFSYJH011YV93A6FEWNP8},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_XXEFA32VWBN7VNBT9JADH6JBR2",
        "url": "https://statorigin.org/stat/stat_XXEFA32VWBN7VNBT9JADH6JBR2",
        "indicator": {
          "slug": "new-active-substance-approvals",
          "name": "New active substance approvals",
          "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 50,
        "value_text": "50",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_XXEFA32VWBN7VNBT9JADH6JBR2",
          "bibtex": "@misc{cirs2025activeh6jbr2,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_XXEFA32VWBN7VNBT9JADH6JBR2},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      },
      {
        "id": "stat_AMV8QYAVFBPB1H3DYFVGJH21W6",
        "url": "https://statorigin.org/stat/stat_AMV8QYAVFBPB1H3DYFVGJH21W6",
        "indicator": {
          "slug": "new-active-substance-approvals",
          "name": "New active substance approvals",
          "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "AU",
          "name": "Australia",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 42,
        "value_text": "42",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_AMV8QYAVFBPB1H3DYFVGJH21W6",
          "bibtex": "@misc{cirs2025activejh21w6,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_AMV8QYAVFBPB1H3DYFVGJH21W6},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      },
      {
        "id": "stat_84WCV23H6VE3N5JEVT5K316PE0",
        "url": "https://statorigin.org/stat/stat_84WCV23H6VE3N5JEVT5K316PE0",
        "indicator": {
          "slug": "new-active-substance-approvals",
          "name": "New active substance approvals",
          "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "JP",
          "name": "Japan",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 40,
        "value_text": "40",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_84WCV23H6VE3N5JEVT5K316PE0",
          "bibtex": "@misc{cirs2025active316pe0,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_84WCV23H6VE3N5JEVT5K316PE0},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      },
      {
        "id": "stat_TVS8NZ8FRH1ZBBSQJ144G7R723",
        "url": "https://statorigin.org/stat/stat_TVS8NZ8FRH1ZBBSQJ144G7R723",
        "indicator": {
          "slug": "new-active-substance-approvals",
          "name": "New active substance approvals",
          "definition": "Total count of new active substance marketing approvals granted by regulatory authorities during the period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "EU",
          "name": "European Union",
          "type": "bloc"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 39,
        "value_text": "39",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Centre for Innovation in Regulatory Science",
          "org_short_name": "CIRS",
          "org_url": "https://cirsci.org",
          "org_tier": 3,
          "document_title": "New Drug Approvals by Six Major Authorities 2016-2025",
          "document_url": "https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/",
          "document_type": "press_release",
          "locator": "Key Findings",
          "quote": "In 2025, FDA granted the highest number of new active substance approvals (50), followed by Health Canada (44), TGA (42), PMDA (40), EMA (39), and Swissmedic (34).",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T16:36:08.269Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Centre for Innovation in Regulatory Science. (2025). New Drug Approvals by Six Major Authorities 2016-2025. Retrieved September 17, 2026, from https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Via StatOrigin, https://statorigin.org/stat/stat_TVS8NZ8FRH1ZBBSQJ144G7R723",
          "bibtex": "@misc{cirs2025activeg7r723,\n  author       = {{Centre for Innovation in Regulatory Science}},\n  title        = {New Drug Approvals by Six Major Authorities 2016-2025},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_TVS8NZ8FRH1ZBBSQJ144G7R723},\n  note         = {Original source: https://cirsci.org/publications/cirs-rd-briefing-106-new-drug-approvals-by-six-major-authorities-2016-2025/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T16:36:08.269Z"
      }
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 14,
    "note": "Statistics are capped at 100 per request. Use /statistics?source_org=centre-for-innovation-in-regulatory-science with a cursor to page through everything."
  }
}